TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
table of content
1.1 Implantable Drug-Eluting Devices Product Introduction
1.2.1 United Statesn Implantable Drug-Eluting Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Diabetes
1.2.3 Contraception
1.2.4 HIV/AIDS Prevention
1.2.5 Chronic Pain Management
1.2.6 Cardiovascular
1.2.7 Ophthalmology
1.2.8 Oncology
1.2.9 Others
1.3.1 United States Implantable Drug-Eluting Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Implantable Drug Infusion Pumps
1.3.3 Intraocular Drug-Eluting Devices
1.3.4 Contraceptive Drug-Eluting Devices
1.3.5 Drug-Eluting Stents
1.3.6 Others
1.4 United States Implantable Drug-Eluting Devices Sales Estimates and Forecasts 2019-2030
1.5 United States Implantable Drug-Eluting Devices Hydrocephalus Shunts Revenue Estimates and Forecasts 2019-2030
1.6 Study Objectives
1.7 Years Considered
2.1 United States Implantable Drug-Eluting Devices Sales by Manufacturers
2.1.1 United States Implantable Drug-Eluting Devices Sales by Manufacturers (2019-2024)
2.1.2 United States Implantable Drug-Eluting Devices Sales Market Share by Manufacturers (2019-2024)
2.1.3 Top Largest Manufacturers of Implantable Drug-Eluting Devices in 2023 in United States
2.2 United States Implantable Drug-Eluting Devices Revenue by Manufacturers
2.2.1 United States Implantable Drug-Eluting Devices Revenue by Manufacturers (2019-2024)
2.2.2 United States Implantable Drug-Eluting Devices Revenue Market Share by Manufacturers (2019-2024)
2.2.3 United States Top Companies by Implantable Drug-Eluting Devices Revenue in 2023
2.3 United States Implantable Drug-Eluting Devices Sales Price by Manufacturers (2019-2024)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)
2.4.2 United States Implantable Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 United States Implantable Drug-Eluting Devices Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3.1 Implantable Drug-Eluting Devices Market Size by Region: 2019-2030
3.1.1 United States Implantable Drug-Eluting Devices Sales by Region: 2019-2024
3.1.2 United States Implantable Drug-Eluting Devices Sales Forecast by Region (2025-2030)
3.1.3 United States Implantable Drug-Eluting Devices Revenue by Region: 2019-2024
3.1.4 United States Implantable Drug-Eluting Devices Revenue Forecast by Region (2025-2030)
4.1 United States Implantable Drug-Eluting Devices Sales by Type
4.1.1 United States Implantable Drug-Eluting Devices Historical Sales by Type (2019-2024)
4.1.2 United States Implantable Drug-Eluting Devices Forecasted Sales by Type (2025-2030)
4.1.3 United States Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2030)
4.2 United States Implantable Drug-Eluting Devices Revenue by Type
4.2.1 United States Implantable Drug-Eluting Devices Historical Revenue by Type (2019-2024)
4.2.2 United States Implantable Drug-Eluting Devices Forecasted Revenue by Type (2025-2030)
4.2.3 United States Implantable Drug-Eluting Devices Revenue Market Share by Type (2019-2030)
4.3 United States Implantable Drug-Eluting Devices Price by Type
4.3.1 United States Implantable Drug-Eluting Devices Price by Type (2019-2024)
4.3.2 United States Implantable Drug-Eluting Devices Price Forecast by Type (2025-2030)
5.1 United States Implantable Drug-Eluting Devices Sales by Application
5.1.1 United States Implantable Drug-Eluting Devices Historical Sales by Application (2019-2024)
5.1.2 United States Implantable Drug-Eluting Devices Forecasted Sales by Application (2025-2030)
5.1.3 United States Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2030)
5.2 United States Implantable Drug-Eluting Devices Revenue by Application
5.2.1 United States Implantable Drug-Eluting Devices Historical Revenue by Application (2019-2024)
5.2.2 United States Implantable Drug-Eluting Devices Forecasted Revenue by Application (2025-2030)
5.2.3 United States Implantable Drug-Eluting Devices Revenue Market Share by Application (2019-2030)
5.3 United States Implantable Drug-Eluting Devices Price by Application
5.3.1 United States Implantable Drug-Eluting Devices Price by Application (2019-2024)
5.3.2 United States Implantable Drug-Eluting Devices Price Forecast by Application (2025-2030)
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Overview
6.1.3 Medtronic in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Implantable Drug-Eluting Devices Product Introduction
6.1.5 Medtronic Recent Developments
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Overview
6.2.3 Boston Scientific Corporation in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Product Introduction
6.2.5 Boston Scientific Corporation Recent Developments
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Overview
6.3.3 Abbott Laboratories in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Laboratories Implantable Drug-Eluting Devices Product Introduction
6.3.5 Abbott Laboratories Recent Developments
6.4 Becton, Dickinson and Company
6.4.1 Becton, Dickinson and Company Corporation Information
6.4.2 Becton, Dickinson and Company Overview
6.4.3 Becton, Dickinson and Company in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.4.4 Becton, Dickinson and Company Implantable Drug-Eluting Devices Product Introduction
6.4.5 Becton, Dickinson and Company Recent Developments
6.5 Merit Medical Systems
6.5.1 Merit Medical Systems Corporation Information
6.5.2 Merit Medical Systems Overview
6.5.3 Merit Medical Systems in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.5.4 Merit Medical Systems Implantable Drug-Eluting Devices Product Introduction
6.5.5 Merit Medical Systems Recent Developments
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Overview
6.6.3 Johnson & Johnson in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Implantable Drug-Eluting Devices Product Introduction
6.6.5 Johnson & Johnson Recent Developments
6.7 Integra LifeSciences
6.7.1 Integra LifeSciences Corporation Information
6.7.2 Integra LifeSciences Overview
6.7.3 Integra LifeSciences in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.7.4 Integra LifeSciences Implantable Drug-Eluting Devices Product Introduction
6.7.5 Integra LifeSciences Recent Developments
6.8 Teleflex Incorporated
6.8.1 Teleflex Incorporated Corporation Information
6.8.2 Teleflex Incorporated Overview
6.8.3 Teleflex Incorporated in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.8.4 Teleflex Incorporated Implantable Drug-Eluting Devices Product Introduction
6.8.5 Teleflex Incorporated Recent Developments
6.9 West Pharmaceutical Services, Inc.
6.9.1 West Pharmaceutical Services, Inc. Corporation Information
6.9.2 West Pharmaceutical Services, Inc. Overview
6.9.3 West Pharmaceutical Services, Inc. in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.9.4West Pharmaceutical Services, Inc. Implantable Drug-Eluting Devices Product Introduction
6.9.5 West Pharmaceutical Services, Inc. Recent Developments
6.10 C.R. Bard (acquired by Becton, Dickinson and Company)
6.10.1 C.R. Bard (acquired by Becton, Dickinson and Company) Corporation Information
6.10.2 C.R. Bard (acquired by Becton, Dickinson and Company) Overview
6.10.3 C.R. Bard (acquired by Becton, Dickinson and Company) in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.10.4 C.R. Bard (acquired by Becton, Dickinson and Company) Implantable Drug-Eluting Devices Product Introduction
6.10.5 C.R. Bard (acquired by Becton, Dickinson and Company) Recent Developments
7.1 Implantable Drug-Eluting Devices Industry Chain Analysis
7.2 Implantable Drug-Eluting Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Drug-Eluting Devices Production Mode & Process
7.4 Implantable Drug-Eluting Devices Sales and Marketing
7.4.1 Implantable Drug-Eluting Devices Sales Channels
7.4.2 Implantable Drug-Eluting Devices Distributors
7.5 Implantable Drug-Eluting Devices Customers
8.1.1 Implantable Drug-Eluting Devices Industry Trends
8.1.2 Implantable Drug-Eluting Devices Market Drivers
8.1.3 Implantable Drug-Eluting Devices Market Challenges
8.1.4 Implantable Drug-Eluting Devices Market Restraints
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
